Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Kristoffer Hellstrand

Professor/ chief physician

Kristoffer Hellstrand
Professor/ chief physician
kristoffer.hellstrand@microbio.gu.se
+46 31 786 6672

Room number: Cancercentrum
Postal Address: Box 425, 40530 Göteborg
Visiting Address: Medicinaregatan 1F , 41390 Göteborg


Department of Infectious Diseases at Institute of Biomedicine (More Information)
Box 480
405 30 Göteborg
0313421000
Visiting Address: Guldhedsgatan 10 A-B , 413 46 Göteborg

Latest publications

IFNL4 Genotypes Predict Clearance of RNA Viruses in Rwandan Children With Upper Respiratory Tract Infections
Belson Rugwizangoga, Maria Andersson, Jean-Claude Kabayiza, Malin S. Nilsson, Brynja Armannsdóttir et al.
Frontiers in Cellular and Infection Microbiology, Journal article 2019
Journal article

Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade
Hanna Grauers Wiktorin, Malin S. Nilsson, Roberta Kiffin, Frida Ewald Sander, Brianna Lenox et al.
Cancer Immunology Immunotherapy, Journal article 2019
Journal article

Showing 91 - 100 of 115

2004

2003

Immune response in blood and tumour tissue in patients with metastatic malignant melanoma treated with IL-2, IFN alpha and histamine dihydrochloride.
Andreas Schjellerup Jørkov, Frede Donskov, Torben Steiniche, Annika Ternesten-Bratel, Peter Naredi et al.
Anticancer research, Journal article 2003
Journal article

2002

Interleukin-2 and histamine dihydrochloride in metastatic melanoma.
Sanjiv S Agarwala, Kristoffer Hellstrand, Peter Naredi
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Journal article 2002
Journal article

Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II study.
F Donskov, H von der Maase, R Henriksson, U Stiemer, P Wersäll et al.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Journal article 2002
Journal article

Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma.
Sanjiv S Agarwala, John Glaspy, Steven J O'Day, Malcolm Mitchell, John Gutheil et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Journal article 2002
Journal article

2001

Showing 91 - 100 of 115

Page Manager: Chatrine Butler|Last update: 8/28/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
http://biomedicine.gu.se/biomedicine/about-us/staff/department-of-infectious-diseases/?publicationPageNumber=10&selectedTab=2&languageId=100001&disableRedirect=true&returnUrl=http%3A%2F%2Fbiomedicine.gu.se%2Fpersonal%2Favd-for-infektionssjukdomar%2F%3FuserId%3Dxhellk%26userName%3DKristoffer%2BHellstrand&userId=xhellk&userName=Kristoffer+Hellstrand
Utskriftsdatum: 2020-01-19